Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study. - Cousin S; Blay JY; Garcia IB; de Bono JS; Le Tourneau C; Moreno V; Trigo J; Hann CL; Azad AA; Im SA; Cassier PA; French CA; et al. (International journal of cancer, 2022)